San Francisco, CA, United States of America

Louis R Bucalo

This inventor holds 45 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Implantable Medical Devices. Top assignees: Investors in Ventures, Inc., Titan Pharmaceuticals, Inc., Microbyx Corporation. Active years: 1976-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Louis R Bucalo. Retrieved from https://idiyas.com/inventor/louis-r-bucalo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 45 

% Patents Active = 91.1


 

Average Co-Inventor Count = 1.2

ph-index = 18

Forward Citations = 938(Granted Patents)


Location History:

  • New York, NY (US) (1976)
  • Holbrook, NY (US) (1976 - 1982)
  • San Francisco, CA (US) (1995 - 2003)
  • Miami Beach, FL (US) (2010)
  • Lauderdale By The Sea, FL (US) (2013)
  • Miami, FL (US) (2012 - 2016)

Company Filing History:


Years Active: 1976-2016

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Implantable Devices
Fluid Collection
Dopamine Agonist
Buprenorphine
Weight Loss
Gene Transfer
Safety Helmet
Surgical Methods
Magnetic Treatment
Absorbable Implants
Biopsy Instruments
Microorganism Detection
45 patents (USPTO):Explore Patents

Title: Innovation and Contribution of Louis R Bucalo in Medical Devices

Introduction

Louis R Bucalo, a prominent inventor based in San Francisco, CA, has made significant contributions to the field of medical devices, particularly focusing on treatments for neurological conditions. With an impressive portfolio of 45 patents, Bucalo has demonstrated a commitment to advancing healthcare technologies for the benefit of patients.

Latest Patents

One of Bucalo's latest innovations is the "Implantable polymeric device for sustained release of dopamine agonist." This invention is designed for the treatment of Parkinson's disease and other conditions where dopamine agonists are beneficial. The device comprises a biocompatible, non-erodible polymeric system that facilitates continuous release of the dopamine agonist with generally linear kinetics over extended durations. The mechanism involves pores that form on the surface of the polymeric matrix, allowing for the controlled release of the therapeutic agent. This device is intended for subcutaneous administration, offering a promising solution for individuals requiring ongoing treatment.

Career Highlights

Throughout his career, Louis R Bucalo has worked with various organizations that focus on innovative healthcare solutions. His efforts have not only resulted in an extensive patent portfolio but have also established him as a respected figure in the medical technology sector.

Collaborations

Bucalo has collaborated with talented professionals such as Brian D Bucalo and Rajesh A Patel. Working alongside these individuals, he has been able to leverage collective expertise to further enhance his inventions and contribute to the medical device field effectively.

Conclusion

Louis R Bucalo's work in the domain of implantable medical devices exemplifies the impact of innovation in improving patient outcomes. His patented technologies, especially those targeting Parkinson's disease, reflect a dedicated approach to tackling complex health challenges. As he continues to explore new avenues for invention, the future of medical technologies looks promising with visionaries like Bucalo at the forefront.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…